These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1385973)

  • 41. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers.
    Farmer K; Gunn T; Woodfield DG
    N Z Med J; 1987 Jul; 100(827):412-4. PubMed ID: 2967932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The prevalence of the HBsAg carrier state among pregnant women and its effect on newborn infants. IV. Our experience in using hepatitis B vaccine and hepatitis B immunoglobulin to immunize infants born to mothers who carry HBsAg].
    Iliev B; Stambolov B; Marinova E; Khitkova Kh; Khristov M
    Akush Ginekol (Sofiia); 1989; 28(6):37-42. PubMed ID: 2633642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progress of the neonatal hepatitis B immunisation programme in Northland.
    Salmond C; Bandaranayake D
    N Z Med J; 1991 Jun; 104(913):233. PubMed ID: 1828869
    [No Abstract]   [Full Text] [Related]  

  • 45. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1989 Jun; 7(1):37-40. PubMed ID: 2526633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hepatitis B virus in schools; a risk?].
    Versteegh FG; Wauters EA; Roord JJ
    Ned Tijdschr Geneeskd; 1991 Mar; 135(12):508-11. PubMed ID: 1827512
    [No Abstract]   [Full Text] [Related]  

  • 47. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
    Danielsson N; Fakakovikaetau T; Szegedi E
    Vaccine; 2009 Jul; 27(33):4462-7. PubMed ID: 19508908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Universal hepatitis B vaccination: the economics of prevention.
    Krahn MD; Detsky AS
    CMAJ; 1992 Jan; 146(1):19-21. PubMed ID: 1530815
    [No Abstract]   [Full Text] [Related]  

  • 49. [Perinatal transmission of the hepatitis B virus and its prevention].
    Stránský J
    Cesk Pediatr; 1989 Nov; 44(11):658-60. PubMed ID: 2534508
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevention of hepatitis B infection: the appropriate strategy for India.
    Aggarwal R; Naik SR
    Natl Med J India; 1994; 7(5):216-20. PubMed ID: 7827601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B vaccines--to switch or not to switch.
    Hollinger FB
    JAMA; 1987 May; 257(19):2634-6. PubMed ID: 2952813
    [No Abstract]   [Full Text] [Related]  

  • 52. [Efficacy of domestic hepatitis B viral vaccines in preventing transmission of E antigen from mothers to newborn infants].
    Kang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 1986 Apr; 7(2):81-3. PubMed ID: 3742571
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers.
    Hsu HM; Chen DS; Chuang CH; Lu JC; Jwo DM; Lee CC; Lu HC; Cheng SH; Wang YF; Wang CY
    JAMA; 1988 Oct; 260(15):2231-5. PubMed ID: 2971827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modern vaccines. Hepatitis.
    Eddleston A
    Lancet; 1990 May; 335(8698):1142-5. PubMed ID: 1971874
    [No Abstract]   [Full Text] [Related]  

  • 55. The dose of hepatitis B vaccine.
    Seville P
    N Z Med J; 1988 Nov; 101(857):774. PubMed ID: 2972946
    [No Abstract]   [Full Text] [Related]  

  • 56. [Immunogenicity and long-term effectiveness of the hepatitis B vaccine in newborns from HBsAg-positive mothers].
    Torres JM; Bruguera M; Fos E; Mayor A; Hierro FR
    Med Clin (Barc); 1990 Sep; 95(7):247-9. PubMed ID: 2149403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simultaneous use of recombinant and plasma derived hepatitis B vaccines in neonates and infants.
    Arya SC; Ashraf SJ; Singh LM; Tajuddin S; Nanda V; Salah el-din N; Bano I; Ali M
    J Trop Pediatr; 1990 Oct; 36(5):269-70. PubMed ID: 2149394
    [No Abstract]   [Full Text] [Related]  

  • 58. Two-year study of passive-active immunization for prevention of hepatitis B infection in newborns.
    Theppisai U; Thanuntaseh C; Chiewsilp P; Siripoonya P
    J Med Assoc Thai; 1988 Aug; 71(8):413-6. PubMed ID: 2978040
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatitis B vaccination.
    Turner B
    N Z Med J; 1989 Feb; 102(862):83. PubMed ID: 2521929
    [No Abstract]   [Full Text] [Related]  

  • 60. Hepatitis B vaccines.
    Zuckerman AJ
    Postgrad Med J; 1986; 62 Suppl 2():3-10. PubMed ID: 2959911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.